Doug Bosley has completed some of the most challenging marathon swims in the world, including the cross-continental Hellespont Dardanelles swim, the Maui Channel swim, the Boston Harbor Swim and the St. Croix Reef swim. He has also participated in nearly 30 Swim Across America swims, including Boston and San Francisco.
While those swims were intense, Doug is now facing one of his toughest battles yet: beating acral lentiginous melanoma, a rare form of skin cancer that has sadly spread and metastasized. Despite his diagnosis, Doug’s sense of humor remains intact. He colors his story with anecdotes, punchlines and heartfelt emotion.
“In March 2024, I discovered a very tiny dot on my heel; it was no bigger than an eraser head. So I got it checked out and was diagnosed with a rare form of skin cancer. Not exactly what you want to hear,” Doug shared lightheartedly.
Doug Bosley (back row, center) and Team Festivus at the 2023 Swim Across America – Boston open water swim.
Doug began treatment at Mass General Cancer Center, one of the beneficiaries of the Swim Across America – Boston community swim. The swim also supports Dana-Farber Cancer Institute. Unfortunately, the cancer has quickly progressed and has spread to his liver and brain.
After initial treatments were unsuccessful, Doug was put on BRAF therapy, a combination of medicines that can shrink or slow the growth of metastatic melanoma in those whose tumors have a BRAF mutation. The treatment helped with his liver and lymph nodes but not his brain due to the blood-brain barrier.
He is currently being treated with two immunotherapy medicines – Yervoy and Opdivo – both which received early-stage grant funding from Swim Across America and are FDA approved for treating several different types of cancer.
“I’m doing ok, but the effects of my treatments are taking a toll,” said Doug. “My skin is incredibly sensitive, my feet are swollen to the point where it’s difficult to walk around, my head is foggy, and I have no saliva. But I’m sitting here, employed and engaged to be married – so that’s a good thing.”
Yes, Doug is engaged! After Doug was diagnosed, he proposed to his longtime girlfriend, Laura Lipcsei. The couple splits their time between their house in Somerville, Massachusetts, and the lake cabin they built together in Ontario, Canada.
“I said to Laura, ‘Now is the time to get married because I don’t know where I’ll be in a year,” joked Doug.
In addition to being thankful for Laura, Doug expresses his appreciation for his Swim Across America family, who have supported him through this journey.
Doug, back row center, participated in the 2009 Swim Across America – Boston Harbor swim.
“My Swim Across America family in Boston means everything to me. We started doing the swims as something fun to do together. Somewhere along the way, it became something more emotional. We’d swim, have fun, have a good cry, then come back the next year. Thirty years later and we’re still here,” shared Doug.
One member of Doug’s SAA-Boston swim group has helped him tremendously. Rick Osterberg, who himself is a cancer survivor and also received an immunotherapy pioneered with funding provided by Swim Across America, is Doug’s “cancer coach” and they swim together on Team Festivus.
“So between my wedding, turning 62 and the August 9 SAA-Boston swim, I’ve got a lot to look forward to this summer! I really want to be up there sharing my story with everyone who has supported me this past year.” said Doug.
If you’re inspired to support Doug and Team Festivus, give here.
Read or watch local stories featuring the Swim Across America – Tampa community to learn about their impact. Learn more about the event and beneficiary, Johns Hopkins All Children’s Hospital, at swimacrossamerica.org/tampa.
The Promising Study Found that 80% of Patients with Mismatch Repair-Deficient (MMRd) Solid Tumors Treated with Immunotherapy Avoided Surgery
The New England Journal of Medicinepublished a paper on April 27, 2025, that presents exciting new results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) gastrointestinal oncologists Andrea Cercek, MD, and Luis Diaz Jr., MD, that demonstrates how immunotherapy alone can help patients with MMRd cancers avoid surgery and preserve their quality of life. The results, presented simultaneously at the 2025 American Association of Cancer Research (AACR) Annual Meeting, showed that 80% of patients with several types of cancer treated with immunotherapy did not require surgery, radiation, or chemotherapy after six months of treatment with immunotherapy alone. Swim Across America awarded grants for the early-stage research and continues to award grants for the ongoing clinical trial.
Andrea Cercek, M.D., gastrointestinal oncologist and co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancer at Memorial Sloan Kettering Cancer Center
Mismatch repair deficiency (MMRd) in cancer refers to a situation where tumor cells have defective mismatch repair (MMR) proteins, essential for correcting DNA errors during cell replication. This deficiency leads to the accumulation of mutations, including microsatellite instability (MSI), making tumors more prone to be recognized by the immune system. MMRd status is a significant factor in cancer treatment, particularly for immunotherapy, as it can predict response to immune checkpoint inhibitors.
The standard of care for many cancers that have this specific MMRd genetic mutation has been surgery, radiation, and chemotherapy. Still, the patients who responded positively to this clinical trial did not require surgery to remove an organ and did not experience chemotherapy or radiation, which improved their quality of life. This trial is the first time that immunotherapy has been shown to replace surgery for a variety of solid tumors.
“This study shows that immunotherapy can replace surgery, radiation and chemotherapy for mismatch repair-deficient solid tumors, which could help patients preserve their organs and avoid the harsh side effects of chemo and radiation,” said Andrea Cercek, M.D., gastrointestinal oncologist and co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancer at Memorial Sloan Kettering Cancer Center. “Preserving a patient’s quality of life, while also successfully achieving positive results in eliminating their cancer, is the best possible outcome. They can return to their daily routines and maintain their independence.”
Luis Diaz, M.D., gastrointestinal oncologist and Head of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center
This phase 2 trial is an extension of a groundbreaking study, also funded in part by Swim Across America, in which all rectal cancer patients treated with the immunotherapy dostarlimab experienced a complete clinical response, meaning their tumors disappeared. This was the first time ever that a clinical trial had a 100% positive response rate.
The updated trial included 103 patients with stage 1-3 cancer; 49 with rectal cancer; and 54 with non-rectal cancers, including gastroesophageal, hepatobiliary, colon, genitourinary, and gynecologic. Drs. Cercek and Diaz noted that the 80% response rate in this expanded clinical trial is very exciting for these types of cancer.
“Grants provided by Swim Across America were critical to our initial study and advancing this trial to phase 2,” said Luis Diaz, M.D., gastrointestinal oncologist and Head of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center.
Founded in 1987, Swim Across America has raised more than $100 million to fight cancer. In its 38 years of making waves, thousands of volunteers and Olympians have swum the circumference of the earth three times uniting a movement to fight cancer that has created a groundswell of support spanning all generations. Today, more than 24 communities across the U.S. hold charity swims each year, which support innovative cancer research, detection, and patient programs.
Drs. Andrea Cercek and Luis Diaz spoke at the 2024 Swim Across America – Long Island Sound open water swim
Swim Across America’s funding of clinical trials on a national level has helped contribute to four FDA-approved life-saving immunotherapy cancer treatments: Yervoy, Opdivo, Tecentriq, and Keytruda. Swim Across America awards grant to more than 60 projects each year and there are ten named Swim Across America Labs at major institutions.
In addition to Swim Across America grants, this trial received funding from the National Institutes of Health, National Cancer Institute, Haystack Oncology, and Stand Up To Cancer. MSK also acknowledges support from GSK, whose PD-1 blockade Jemperli (dostarlimab), represents a promising advancement in the treatment of patients.
For more information and to inquire about eligibility for this clinical trial, talk to your oncologist or call MSK at 646-888-4189. You may also reach to info@swimacrossamerica.org and we will help guide you.
Choi’s next generation CAR-T therapy, funded in part by SAA-Boston and SAA-Nantucket, has shown “dramatic and rapid” regression of glioblastoma
With early funding from Swim Across America – Boston and Swim Across America – Nantucket, Dr. Bryan Choi’s research on tandem CAR T-cell therapy for ependymoma was approved for a Phase I trial. The first human patient was infused at the end of April 2023. The results of the first human trials, as described in 2024 by the New England Journal of Medicine, showed “dramatic and rapid” regression of glioblastoma.
In an exclusive briefing to Swim Across America participants, Dr. Bryan Choi, a neurosurgeon and neuro-oncologist at Massachusetts General Cancer Center, delivered an update on his research path.
From left, brain tumors, marked by red and green arrows, disappear a day after CAR-T immunotherapy treatment. From CNN.
The Swim Across America lab visit included not only highlights from on the ongoing Phase I trial, but also a few first-hand stories about the life-changing impacts of the new CAR-T cell therapy for one of the patients, who has chosen to share his story publicly.
Tom Fraser (Patient #2) has shared his story publicly with news outlets that include CNN and New York Magazine.
Tom Fraser, 72, (center, in the blue shirt) was treated with a single infusion of CAR-T cells. Two days later, an MRI showed a decrease in the tumor’s size by 18.5 percent. By day 69, the tumor had decreased by 60.7 percent, and the response was sustained for over 6 months. From The Harvard Gazette.
CAR T-cell therapy, a type of gene therapy that engineers a patient’s own T-cells (a type of white blood cells) to identify and attack cancer cells by way of their antigen markers, has shown promise in the treatment of blood cancers. The research team created dual antigen-targeting tandem CAR T (TanCART) cells to target heterogeneous solid tumors. Dr. Choi’s research shows that this type of therapy can also be manipulated to treat solid tumors like ependymoma.
At the suggestion of Dr. Howard Weinstein, Unit Chief of Pediatric Hematology/Oncology at Mass General for Children and long-time Swim Across America partner, Dr. Choi applied for a Swim Across America research grant through the internal competitive bid program at Mass General for Children.
Dr. Choi recruiting the next generation of researchers, like SAA – Nantucket supporter, Braden Hussey.
Without the Swim Across America grant, Dr. Choi said, his research likely would have remained unfunded, and neither the FDA approval nor the Phase I Study approval, which is funded by industry investors, would have been possible.
Janel Jorgensen McArdle, Chief Operating Officer of Swim Across America, pointed out that Dr. Choi’s research falls in the “sweet spot” of the high risk, high reward research that Swim Across America is pursuing.
“This promising research aligned perfectly with the opportunities that Swim Across America seeks to support,” said McArdle. “We are so excited that SAA funding could help accelerate it to patient trials – and are thrilled to see the benefits to patients!”
Dr. Choi explained CAR-T cell therapy to the Swim Across America group on April 4, 2025.
After his highly informative presentation, Dr. Choi gave the Swim Across America group a private tour of his lab spaces, which were in the finishing stages of build-out when they toured two years ago.
The group also got to visit the Ether Dome at Mass General, the surgical amphitheater where, in 1846, the first public surgery with anesthesia was performed.
It was an exciting visit for Swim Across America news and for all of the Swim Across America – Boston and Nantucket supporters who were present!
Swim Across America lab visit participants, pictured with Dr. Choi in the Ether Dome at Mass General, site of the first use of anesthesia in public surgery.
Revolutionary CRISPR Gene Editing and Other Cell and Gene Therapy Editing Takes Center Stage in Finding Ways to Effectively Treat Cancer
Swim Across America, the nonprofit funding innovative clinical trials and patient-centered programs for cancer,is proud to announce the award of two $450,000 grants to two of its beneficiaries, Alliance for Cancer Gene Therapy(ACGT) and Dana-Farber Cancer Institute, to support the work of novel gene and base editing techniques used in advanced cancer research, including targeted therapies, immunotherapies and cellular therapies. The two-year grants will specifically support the work of scientific investigators Joseph Fraietta, PhD, at the University of Pennsylvania through ACGT, and Pietro Genovese, PhD, at Dana-Farber Cancer Institute, for their work in groundbreaking cell and gene therapy cancer research. This financial support paves the way for more effective therapies across many cancer types including solid tumors, offering potential new hope for patients with hard to treat cancer types or limited treatment options.
“Gene editing, including CRISPR, are some of the most promising frontiers in cancer research allowing for advances in targeted therapies, immunotherapies, CAR-T cell therapy and early/minimal residual disease detection, diagnostics and cancer vaccines,” said Rob Butcher, CEO of Swim Across America. “These grants to Dr. Fraietta through ACGT, and Dr. Genovese at Dana-Farber, will help accelerate the advancement of potential gene-edited cancer treatments that could transform how we treat patients and their quality of life. Just as our previous funding has helped develop immunotherapy treatments that are saving lives today, we believe these pointed investments will help accelerate the next generation of cancer breakthroughs.”
Joseph Fraietta, PhD
Joseph Fraietta, PhD, through Swim Across America–Fairfield County beneficiary Alliance for Cancer Gene Therapy, is developing an innovative “off-the-shelf” cell therapy for aggressive cancers. His research uses a precise gene-editing tool called a “base editor” to create more effective CAR T cells that can target cancers with KRAS mutations, found in 20-25% of all cancers including lung, colon and pancreatic cancer. His team is also developing “micropharmacies” – immune cells engineered to release powerful cancer-fighting signals directly at tumor sites while minimizing side effects.
Pietro Genovese, PhD
Pietro Genovese, PhD, at Dana-Farber, is taking a revolutionary approach to treating acute myeloid leukemia (AML). Rather than targeting cancer cells directly, his team is creating “stealth” healthy blood cells engineered to survive cancer treatments while allowing the selective elimination of cancer cells. This innovative strategy could provide less toxic treatment options for AML and other blood cancers where traditional therapies often harm healthy cells along with cancerous ones.
“With the current funding landscape and resources potentially constrained, nonprofit organizations play a vital role in ensuring innovative cancer research moves forward,” said Evan Vosburgh, MD, Research and Grants committee chair for Swim Across America. “These targeted grants support precisely the kind of high-risk, high-reward research that could revolutionize cancer treatment, but might otherwise go unfunded. By supporting early-stage research in cell and gene therapy, we’re helping bridge critical funding gaps and accelerating the development of potentially life-saving treatments.”
Swim Across America has raised more than $100 million for cancer research since its founding in 1987 and has a strong track record of funding transformative research, including clinical trials that led to FDA-approved immunotherapy medicines Keytruda, Opdivo, Yervoy and Tecentriq. The organization was also a grant funder of Memorial Sloan Kettering’s landmark clinical trial that achieved a 100% success rate treating advanced rectal cancer patients with dostarlimab.
About Swim Across America Swim Across America hosts open water and pool swims in numerous communities nationwide, from Nantucket to under San Francisco’s Golden Gate Bridge. More than 150 Olympians support the organization, including Michael Phelps, Kate Douglass, Missy Franklin and Ryan Lochte. The organization supports more than 60 cancer research projects annually and has ten named Swim Across America Labs at major institutions nationwide. To learn more visit swimacrossamerica.org or follow on social media @SwimAcrossAmerica on Facebook and @SAASwim on Instagram.
Read or watch local stories featuring the Swim Across America-Nashville community to learn about their impact. Learn more about the event and beneficiary, Vanderbilt-Ingram Cancer Center, at swimacrossamerica.org/nashville.
Berkeley, California Resident is one of the Youngest in History to Complete the Triple Crown of Open Water Swimming and Has Raised More than $125,000 for Cancer Research through Swim Across America
Maya Merhige a 17-year-old marathon swimmer from Berkeley, California, on March 14, 2025, successfully swam New Zealand’s Cook Strait, a 22 km (13.67 mile) body of water and one of the world’s most challenging open water swims. This latest achievement for Merhige comes just eight months after she successfully swam the English Channel in July 2024, becoming one of the youngest swimmers in the world to achieve the Triple Crown of Open Water Swimming. The completion of the Cook Strait makes this her tenth marathon swim — all which have been done to raise funds for cancer research with the nonprofit Swim Across America. Throughout her years of swimming and making waves to fight cancer, Maya has raised an incredible $125,000!
Maya Merhige, third from left, with her support crew after Maya completed the Cook Strait swim.
Merhige completed the Cook Strait swim in 14 hours, eight minutes and 36 seconds. At 17, she joined the ranks of one of the youngest swimmers to successfully conquer this formidable strait. Accompanying Merhige on this journey and on her support boat was her father Chris Merhige, her official timekeeper, friend and open water coach Kelly Gentry, and her godparents Geoff Tennican and Jen Durning, who have been steadfast supporters of Maya’s and who have donated more than $18,000 to her cause to make waves to fight cancer for the nonprofit Swim Across America, the beneficiary of Maya’s swims. Their presence on the support boat provided invaluable encouragement throughout the swim and helped keep Maya going by relaying uplighting and inspiring messages from Maya’s family and friends all around the world who were following her progress.
The Cook Strait is known for its rough and unpredictable water, high winds and abundant marine life. Situated between the North and South islands of New Zealand, the Cook Strait connects the Tasman Sea with the South Pacific Ocean. Both shores are lined with steep cliffs which can create a wind tunnel effect. The strong gusts of wind and tidal flows make it one of the roughest and most unpredictable stretches of water in the world. The challenging conditions have attracted numerous swimmers, many of whom have failed to make the crossing and several who have succeeded.
The water in the Cook Strait during Maya’s swim was a bit rough with 15-to-25 knot winds and 1 metre swells and the water was a chilly 60 degrees with the air temp only 59 degrees fahrenheit. According to marathon swimming rules, Maya swims with only a bathing suit, swim cap and goggles. “This was one of the gutsiest swims I’ve ever seen, and was according to some folks on the boat too,” noted Maya’s father Chris Merhige, who was on the support boat traveling alongside Maya during her swim.
“Swimming the Cook Strait was a hard, but incredible experience,” Maya Merhige said. “The jellyfish stings, unpredictable currents and wind presented unique challenges, but knowing that my efforts contribute to cancer research kept me motivated. Having my godparents by my side meant the world to me—they have been some of my strongest supporters, always believing in me and helping to make these swims possible.”
Completing the Cook Strait brings Merhige closer to completing the Ocean’s Seven Swims – the most challenging open water swims in the world. Since 2020, she has completed the Catalina Channel, Molokai Channel, English Channel and Cook Strait – with still to come the North Channel, Tsugaru Strait and Strait of Gibraltar.
Maya and Swim Across America – San Francisco co-event director, Jackie NeJaime
Merhige’s previous accomplishments include becoming the youngest woman to swim the 20-mile Catalina Channel at just 14 years old, completing the 28.5-mile Manhattan 20 Bridges swim at 15, and crossing the English Channel at 16, earning her the Triple Crown of Open Water Swimming.
Merhige’s commitment to open water swimming began at age nine when she joined her first Swim Across America – San Francisco open water swim, where she swam with Team Susan Survives! in honor of a family friend and three-time cancer survivor, Susan Helmrich. Since then, she has participated in the annual swim, raising more than $125,000 for pediatric cancer research with Swim Across America – San Francisco’s local beneficiary UCSF Benioff Children’s Hospitals.
While raising funds for cancer research and new treatments in support of friends and family members battling cancer has been her inspiration for swimming, writing their names on her swim cap to bring them on the journey with her, Maya has had her own personal health challenges, including discovering a benign pancreatic tumor in 2023 after a ski accident. She has had some ongoing health challenges stemming from the issue and has had her own hospital stays and surgeries, which have only deepened her empathy for cancer patients and strengthened her resolve to support cancer research and help fund new and better treatments.
This fall, Merhige will be starting her freshman year at college, but still hopes to participate in the annual Swim Across America – San Francisco open water swim on September 21, 2025, marking her ninth year swimming in the event. To learn more about Merhige’s amazing swimming accomplishments and to support her fundraising efforts, visitswimacrossamerica.org/maya.
Founded in 1987, Swim Across America has raised more than $100 million to fight cancer. In its 38 years of making waves, thousands of swimmers and Olympians have swum the circumference of the earth three times uniting a movement to fight cancer that has created a groundswell of support spanning all generations. Today, more than 24 communities across the U.S. hold charity swims each year, which support innovative cancer research, detection and patient programs. Swim Across America’s grants have helped support the research and clinical trials for FDA approved immunotherapy medicines: Keytruda, Opdivo, Yervoy, and Tecentriq. Swim Across America is also a grant funder of the successful clinical trial at Memorial Sloan Kettering that was published in The New England Journal of Medicine and showed a 100 percent success rate in treating patients in a phase 2 clinical trial for advanced rectal cancer with dostarlimab, an immunotherapy treatment produced by GlaxoSmithKline. Swim Across America awards grant to more than 60 projects each year and there are ten named Swim Across America Labs at major institutions.
More than 150 Olympians and marathon swimmers support Swim Across America on a regular basis, including Kate Douglass, Michael Phelps, Craig Beardsley, Elizabeth Beisel, Missy Franklin, Ryan Held, Gretchen Walsh, Donna de Varona, Rowdy Gaines, Janel Jorgensen McArdle, Bobby Hackett, Ryan Lochte, Glenn Mills, Cristina Teuscher and many more.
Swim Across America, Inc. (SAA) raises money and awareness for cancer research, prevention and treatment through swimming-related events. With the help of volunteers, and Olympians, Swim Across America is an innovator and leader in giving hope to those fighting cancer. To learn more visit swimacrossamerica.org, Facebook @SwimAcrossAmerica, and Instagram @SAASwim.
Francesca “Frankie” Grieco-Routh is a kind and caring 13-year-old who loves making art, reading, listening to music, and cheering on her two younger sisters, Emmersan and Augustine. She’s also a leukemia survivor celebrating 10 years of being minimal residual disease (MRD) negative—meaning no cancer cells can be detected in her blood.
“Frankie is so full of life, and her personality is most like Buddy from the movie Elf. She’s full of joy and laughter and wants everyone around her to be happy and comforted,” shared her mother, Giselle. “She loves painting, spending time with family, and being with her service dog, Luna. She’s our warrior.”
This year, the Grieco-Routh family will attend Swim Across America – Tampa Bay on May 10, supported by Emmersan’s team, Team BEST. Emmersan, or Emmie, is an 11-year-old competitive swimmer with St. Petersburg Aquatics and will be a rookie swimmer at this year’s event. She will be joined by friends and teammates to honor her sister Frankie.
The Grieco-Routh family
“Whatever we do, we do it as a family, and we go all in,” said Giselle. “So when Coach Brackin met Emmie and heard our family’s story, she graciously offered to have their team fundraise in Frankie’s honor. Emmie is excited to swim, and doing it for her sister makes it even more special.”
Giselle and her husband, Ryan, moved Frankie, Emmie, and Augustine (August) from Southern California to St. Petersburg, Florida, to be closer to family and ensure Frankie could continue her long-term maintenance care at Johns Hopkins All Children’s Hospital (JHACH). Swim Across America – Tampa Bay raises funds for immunotherapy research at JHACH and has contributed over $2 million to its beneficiaries since 2012.
“The support we’ve received since moving to St. Petersburg has been incredible—not just from the swimming community, but from the amazing team at JHACH. The care Frankie has received there is unmatched,” said Giselle.
Frankie was just three years old when she was diagnosed with leukemia. After months of unexplained illness and several misdiagnoses, Giselle pushed doctors to order a complete series of tests. That’s when they received the devastating news no family wants to hear.
Frankie saw her first movie at the hospital theater while receiving treatment for leukemia.
“The doctor called me and told me to get Frankie to the hospital immediately. Her white blood cell count was extremely high and her body was shutting down. She was rushed into treatment and spent two weeks in the hospital, receiving intense chemotherapy daily and undergoing countless procedures, including weekly spinal taps,” said Giselle.
At the time, Giselle and Ryan had Frankie, 10-month old Emmie, and just found out she was pregnant with their third daughter.
“To say it was overwhelming would be an understatement!” joked Giselle.
Despite everything, Frankie amazed everyone with her strength. Because her immune system was severely compromised, she couldn’t leave her hospital room, but that didn’t stop her from keeping herself entertained with art and movies.
“She would even make art out of her food—stacking bagels and spreading jelly on trays! She was so strong despite being in so much pain,” Giselle shared.
Frankie’s strength extended beyond her own battle—she found ways to comfort other families fighting similar struggles. Even if she couldn’t leave her room, she still sent love and support from afar.
“Every time we heard another family having a tough time—a child crying or a mother sobbing through a broken heart—we’d send them love through our ‘magic fingers,’” Giselle said, as she and Frankie wiggled their fingers in the air.
August, Emmie and Frankie Grieco-Routh
As Emmie takes on open water swimming with her team, Frankie, Giselle, Ryan, and August will be on the beach cheering her on. No matter the challenge, they face it together.
“Whether it’s swimming, gymnastics, or leukemia, we are each other’s biggest cheerleaders and support system. Seeing our daughters support each other through thick and thin makes us incredibly proud.”
If you are inspired to support Frankie, Emmie and Team BEST, give here.
Wilcox and Buttigieg Bring Biotech, Science, Financial, Hospitality and Real Estate Expertise to Help Grow Swim Across America’s Impact and Mission
Harry Wilcox and Tim Buttigieg have been appointed to the Swim Across America board of directors.
Swim Across America, a national nonprofit dedicated to funding cancer research and patient programs through funds raised with charity swims, is pleased to announce the appointment of two distinguished leaders to its board of directors: Harry Wilcox, a life sciences entrepreneur, and Tim Buttigieg, a hospitality and real estate executive. Their extensive backgrounds in science, business, finance and community engagement will help advance Swim Across America’s mission and expand its impact.
Wilcox, based in Boston, has spent more than 30 years in executive leadership roles in the biotech, life sciences and financial sectors. His career includes positions with Exact Sciences, Cambridge NeuroScience, Charles River Ventures, BG Medicine, and YourBio Health Inc. Most recently, he served as general partner with Flagship Pioneering, a $14 billion life sciences company creation firm, where he oversaw financial operations and investments in biotechnology, health, and sustainability companies, including Seahorse Bioscience, Indigo Agriculture, and Novomer.
“My college roommate Jim Meehan and my wife, Patricia Hambrick, are both Swim Across America participants who introduced me to the organization,” Wilcox said. “I admire the approach Swim Across America takes in awarding grants that drive innovation in cancer research and detection. At this stage in my life, I’m excited to offer my time, experience, and resources to make a meaningful impact on the mission of helping innovate new treatments for cancer. I am delighted to join the board and work closely with leadership in accomplishing this goal.”
Buttigieg, based in New York City, has an extensive background in hospitality and real estate. His career includes roles with Brookfield Asset Management and previously PwC. Additionally, he chairs Swim Across America’s associate board, a group of emerging leaders dedicated to supporting the organization’s mission. Buttigieg has been involved with Swim Across America for more than a decade, starting as a participant and fundraiser in his teenage years.
“The impact of Swim Across America’s grants has benefited individuals I personally know,” Buttigieg said. “As my professional career has grown, I’ve wanted to give back more to this community, and leading the associate board has been an honor. I look forward to continuing my contributions as a member of the board of directors.” Swim Across America CEO Rob Butcher welcomed both new board members, highlighting their expertise and dedication to the cause. “Harry has been a committed volunteer and supporter of Swim Across America, and his entrepreneur energy and relationships will help us make a bigger impact,” Butcher said. “Tim’s deep understanding of hospitality and customer experience aligns with our mission of offering best-in-class charity programs. His leadership of the associate board has brought in a new generation, and we are thrilled to have him join the board of directors.”
Founded in 1987, Swim Across America has raised more than $100 million to fight cancer. In its 37 years of making waves, thousands of swimmers and Olympians have swum the circumference of the earth three times uniting a movement to fight cancer that has created a groundswell of support spanning all generations. Today, more than 24 communities hold charity swims each year, which support innovative cancer research, detection and patient programs.
Swim Across America grants helped support the research and clinical trials for FDA approved immunotherapy medicines: Keytruda, Opdivo, Yervoy, and Tencentriq. Swim Across America is also a grant funder of the successful clinical trial at Memorial Sloan Kettering that was published in The New England Journal of Medicine and showed a 100 percent success rate in treating patients in a phase 2 clinical trial for advanced rectal cancer with dostarlimab, an immunotherapy treatment produced by GlaxoSmithKline. Swim Across America awards grant to more than 60 projects each year and there are ten named Swim Across America Labs at major institutions including: Children’s Healthcare of Atlanta, John Hopkins Medicine Baltimore, Rush University Medical Center Chicago, Baylor Scott & White Charles A. Sammons Cancer Center in Dallas, Memorial Sloan Kettering Cancer Center New York, Infusion Center at Nantucket Cottage Hospital, UCSF Benioff Children’s Hospital Oakland and San Francisco, Fred Hutch Cancer Center, The Swim Across America Pediatric Research Lab at Columbia University Medical Center New York, and at Meyer Cancer Center at Weill Cornell Medicine.
To learn more about Swim Across America or to register for a community charity swim, you can visit swimacrossamerica.org.
Swim Across America is proud to announce a partnership with the American Swimming Coaches Association (ASCA) to sponsor a scholarship for a deserving coach to attend the 2025 ASCA World Clinic in Reno, Nevada, September 2-5.
The Swim Across America Scholarship provides full registration for the ASCA World Clinic and covers accommodation at the Peppermill Reno hotel and up to $500 for travel.
The ASCA World Clinic, now in its 58th year, is the largest and most comprehensive annual gathering in the sport of swimming. The event features 50 speakers covering a wide range of topics, an expansive exhibition hall, coaching demonstration at an Endless Pool, and numerous socials and networking opportunities.
This initiative is part of SAA’s commitment to supporting ASCA advancing the sport of swimming and the professional growth of dedicated coaches across the nation.
Applicants must be ASCA members who have never attended a World Clinic. Interested candidates are encouraged to complete the online application by February 28, 2025. The scholarship recipient will be notified by March 31, 2025.
“We deeply appreciate Swim Across America for their generosity and dedication to supporting the coaching community,” said ASCA CEO Jennifer LaMont. “This scholarship underscores their acknowledgment of the critical role coaches play in developing athletes and teams. We can’t wait to welcome the scholarship recipient to Reno this September.”
For more information about the ASCA World Clinic and the Swim Across America scholarship, and to apply, go to www.ascaworldclinic.com.
About Swim Across America Swim Across America is a nonprofit organization dedicated to raising funds for cancer research through swimming-related events. Since its inception in 1987, Swim Across America has raised over $100M to fund groundbreaking cancer research and clinical trials. Learn more at www.swimacrossamerica.org.
About ASCA The American Swimming Coaches Association (ASCA) is the professional association for swim coaches dedicated to inspiring, supporting, and advocating for coaches in the US and worldwide. Through education, certification, and professional development, ASCA empowers coaches to lead swimmers toward excellence while advancing the sport of swimming. Learn more at www.swimmingcoach.org.
Swim Across America 